COVID-19

[Nature Communications] Scientists longitudinally profiled the early humoral immune response against SARS-CoV-2 in hospitalized coronavirus disease 2019 (COVID-19) patients and quantify levels of pre-existing immunity to OC43, HKU1 and 229E seasonal coronaviruses

[Nature Nanotechnology] Scientists showed that ACE2 nanodecoys derived from human lung spheroid cells could bind and neutralize SARS-CoV-2 and protect the host lung cells from infection.

[Genes & Immunity] The similar role of DAMPs is addressed, that is, of those molecules, which operate upstream of the inflammatory pathway by activating those cells, which ultimately release the cytokines.

[Journal of Cellular and Molecular Medicine] Since angiotensin-converting enzyme 2 (ACE2)-positive cells were hosts for COVID-19, researchers focussed on this cell type to explore the underlying mechanisms of COVID-19.

[LetsGetChecked (BusinessWire, Inc.)] LetsGetChecked announced the authorization of its home collection COVID-19 test for use on anyone age two years and older with guardians supervising the self collection by minors ages 12 to 18 years and performing the sample collection for children ages two to 11 years.

[Journal of Experimental Medicine] Researchers performed multi-omic single-cell immune profiling of 64 COVID-19 patients across the full range of disease severity, from outpatients with mild disease to fatal cases.